{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:00:45Z","timestamp":1791234045465,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07306-4","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:36:59Z","timestamp":1763401019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CBX7 regulates chemotherapy-induced senescence-like growth arrest in multiple myeloma via the ERK\/STAT3\/PIM1 axis"],"prefix":"10.1186","volume":"23","author":[{"given":"Yangyang","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunyi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianshan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"7306_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.25791","volume":"95","author":"SV Rajkumar","year":"2020","unstructured":"Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95:548\u201367.","journal-title":"Am J Hematol"},{"key":"7306_CR2","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1097\/CM9.0000000000002600","volume":"136","author":"J Liu","year":"2023","unstructured":"Liu J, Liu W, Mi L, Cai C, Gong T, Ma J, Wang L. Burden of multiple myeloma in China: an analysis of the global burden of disease, injuries, and risk factors study 2019. Chin Med J (engl). 2023;136:2834\u201338.","journal-title":"Chin Med J (engl)"},{"key":"7306_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97:1086\u2013107.","journal-title":"Am J Hematol"},{"key":"7306_CR4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.4049\/jimmunol.1402643","volume":"195","author":"A Zingoni","year":"2015","unstructured":"Zingoni A, Cecere F, Vulpis E, Fionda C, Molfetta R, Soriani A, Petrucci MT, Ricciardi MR, Fuerst D, Amendola MG, et al. Genotoxic stress induces senescence-associated ADAM10-dependent release of NKG2D MIC ligands in multiple myeloma cells. The J Immunol. 2015;195:736\u201348.","journal-title":"The J Immunol"},{"key":"7306_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","volume":"22","author":"R Di Micco","year":"2021","unstructured":"Di Micco R, Krizhanovsky V, Baker D. d\u2019Adda di fagagna F: cellular senescence in ageing: from mechanisms to therapeutic opportunities. Nat Rev Mol Cell Biol. 2021;22:75\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7306_CR6","doi-asserted-by":"publisher","first-page":"107817","DOI":"10.1016\/j.pharmthera.2021.107817","volume":"223","author":"D Hu","year":"2021","unstructured":"Hu D, Yuan S, Zhong J, Liu Z, Wang Y, Liu L, Li J, Wen F, Liu J, Zhang J. Cellular senescence and hematological malignancies: from pathogenesis to therapeutics. Pharmacol Ther. 2021;223:107817.","journal-title":"Pharmacol Ther"},{"key":"7306_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/479481a","volume":"479","author":"M Serrano","year":"2011","unstructured":"Serrano M. Cancer: final act of senescence. Nature. 2011;479:481\u201382.","journal-title":"Nature"},{"key":"7306_CR8","doi-asserted-by":"crossref","unstructured":"Saleh T, Bloukh S, Carpenter VJ, Alwohoush E, Bakeer J, Darwish S, Azab B, Gewirtz DA. Therapy-induced senescence: an \u201cold\u201d friend becomes the enemy. Cancers (basel). 2020;12.","DOI":"10.3390\/cancers12040822"},{"key":"7306_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic M, Fan DNY, Belenki D, Dabritz JHM, Zhao Z, Yu Y, Dorr JR, Dimitrova L, Lenze D, Monteiro Barbosa IA, et al. Senescence-associated reprogramming promotes cancer stemness. Nature. 2018;553:96\u2013100.","journal-title":"Nature"},{"key":"7306_CR10","doi-asserted-by":"publisher","first-page":"740794","DOI":"10.3389\/fgene.2021.740794","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Ouyang T, Li M, Hong T, Alriashy M, Meng W, Zhang N. CBX7 is dualistic in cancer progression based on its function and molecular interactions. Front Genet. 2021;12:740794.","journal-title":"Front Genet"},{"key":"7306_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1089\/gtmb.2018.0293","volume":"23","author":"X Zhu","year":"2019","unstructured":"Zhu X, Qin M, Li C, Zeng W, Bei C, Tan C, Zhang Y, Shi W, Kong J, Fu Y, Tan S. Downregulated expression of chromobox homolog 7 in hepatocellular carcinoma. Genet Test Mol Biomarker. 2019;23:348\u201352.","journal-title":"Genet Test Mol Biomarker"},{"key":"7306_CR12","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.ejca.2010.05.011","volume":"46","author":"P Pallante","year":"2010","unstructured":"Pallante P, Terracciano L, Carafa V, Schneider S, Zlobec I, Lugli A, Bianco M, Ferraro A, Sacchetti S, Troncone G, et al. The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. Eur J Cancer. 2010;46:2304\u201313.","journal-title":"Eur J Cancer"},{"key":"7306_CR13","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1158\/0008-5472.CAN-08-0695","volume":"68","author":"P Pallante","year":"2008","unstructured":"Pallante P, Federico A, Berlingieri MT, Bianco M, Ferraro A, Forzati F, Iaccarino A, Russo M, Pierantoni GM, Leone V, et al. Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer. Cancer Res. 2008;68:6770\u201378.","journal-title":"Cancer Res"},{"key":"7306_CR14","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.18632\/oncotarget.14037","volume":"8","author":"S Ni","year":"2017","unstructured":"Ni S, Wang H, Zhu X, Wan C, Xu J, Lu C, Xiao L, He J, Jiang C, Wang W, He Z. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN\/Akt signaling in pancreatic cancer. Oncotarget. 2017;8:8010\u201321.","journal-title":"Oncotarget"},{"key":"7306_CR15","doi-asserted-by":"crossref","unstructured":"Jung J, Buisman SC, Weersing E, Dethmers-Ausema A, Zwart E, Schepers H, Dekker MR, Lazare SS, Hammerl F, Skokova Y, et al. CBX7 induces self-renewal of human normal and malignant hematopoietic stem and progenitor cells by canonical and non-canonical interactions. Cell Rep. 2019;26:1906\u201318 e1908.","DOI":"10.1016\/j.celrep.2019.01.050"},{"key":"7306_CR16","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1073\/pnas.0608721104","volume":"104","author":"CL Scott","year":"2007","unstructured":"Scott CL, Gil J, Hernando E, Teruya-Feldstein J, Narita M, Martinez D, Visakorpi T, Mu D, Cordon-Cardo C, Peters G, et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci USA. 2007;104:5389\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7306_CR17","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1242\/dev.091553","volume":"140","author":"L Aloia","year":"2013","unstructured":"Aloia L, Di Stefano B, Di Croce L. Polycomb complexes in stem cells and embryonic development. Development. 2013;140:2525\u201334.","journal-title":"Development"},{"key":"7306_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ncb1077","volume":"6","author":"J Gil","year":"2004","unstructured":"Gil J, Bernard D, Martinez D, Beach D. Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol. 2004;6:67\u201372.","journal-title":"Nat Cell Biol"},{"key":"7306_CR19","doi-asserted-by":"publisher","first-page":"21184","DOI":"10.1038\/s41598-024-72121-8","volume":"14","author":"Y Ding","year":"2024","unstructured":"Ding Y, Huang K, Sun C, Liu Z, Zhu J, Jiao X, Liao Y, Feng X, Guo J, Zhu C, et al. A Bruton tyrosine kinase inhibitor-resistance gene signature predicts prognosis and identifies TRIP13 as a potential therapeutic target in diffuse large B-cell lymphoma. Sci Rep. 2024;14:21184.","journal-title":"Sci Rep"},{"key":"7306_CR20","doi-asserted-by":"crossref","unstructured":"de Magalhaes Jp, Costa J, Toussaint O. HAGR: the human ageing genomic resources. Nucleic Acids Res. 2005;33:D537\u2013543.","DOI":"10.1093\/nar\/gki017"},{"key":"7306_CR21","doi-asserted-by":"crossref","unstructured":"Liu Y, Lomeli I, Kron SJ. Therapy-induced cellular senescence: potentiating tumor elimination or driving cancer resistance and recurrence? Cells. 2024;13.","DOI":"10.20944\/preprints202406.0057.v1"},{"key":"7306_CR22","first-page":"3761","volume":"59","author":"BD Chang","year":"1999","unstructured":"Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel ES, Lausch E, Christov K, Roninson IB. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 1999;59:3761\u201367.","journal-title":"Cancer Res"},{"key":"7306_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0092-8674(02)00734-1","volume":"109","author":"CA Schmitt","year":"2002","unstructured":"Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 2002;109:335\u201346.","journal-title":"Cell"},{"key":"7306_CR24","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1158\/0008-5472.CAN-04-1270","volume":"65","author":"RS Roberson","year":"2005","unstructured":"Roberson RS, Kussick SJ, Vallieres E, Chen SY, Wu DY. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res. 2005;65:2795\u2013803.","journal-title":"Cancer Res"},{"key":"7306_CR25","first-page":"1876","volume":"62","author":"T Poele Rh","year":"2002","unstructured":"Poele Rh T, Okorokov AL, Jardine L, Cummings J, Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 2002;62:1876\u201383.","journal-title":"Cancer Res"},{"key":"7306_CR26","doi-asserted-by":"crossref","unstructured":"Kretowski R, Borzym-Kluczyk M, Cechowska-Pasko M. Hypoxia enhances the senescence effect of bortezomib-the proteasome inhibitor-on human skin fibroblasts. Biomed Res Int. 2014, 2014;196249.","DOI":"10.1155\/2014\/196249"},{"key":"7306_CR27","doi-asserted-by":"publisher","first-page":"960327122112409","DOI":"10.1177\/09603271221124094","volume":"41","author":"L Wang","year":"2022","unstructured":"Wang L, Yin H, Huang S, Huang S, Huang C, Zhang Z, Liu H. Bortezomib induces cellular senescence in A549 lung cancer cells by stimulating telomere shortening. Hum Exp Toxicol. 2022;41:9603271221124094.","journal-title":"Hum Exp Toxicol"},{"key":"7306_CR28","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/febs.16249","volume":"289","author":"Y Takenaka","year":"2022","unstructured":"Takenaka Y, Inoue I, Nakano T, Ikeda M, Kakinuma Y. Prolonged disturbance of proteostasis induces cellular senescence via temporal mitochondrial dysfunction and subsequent mitochondrial accumulation in human fibroblasts. The FEBS J. 2022;289:1650\u201367.","journal-title":"The FEBS J"},{"key":"7306_CR29","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1182\/blood-2008-08-173914","volume":"113","author":"A Soriani","year":"2009","unstructured":"Soriani A, Zingoni A, Cerboni C, Iannitto ML, Ricciardi MR, Di Gialleonardo V, Cippitelli M, Fionda C, Petrucci MT, Guarini A, et al. ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype. Blood. 2009;113:3503\u201311.","journal-title":"Blood"},{"key":"7306_CR30","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1111\/acel.12404","volume":"14","author":"A O\u2019Loghlen","year":"2015","unstructured":"O\u2019Loghlen A, Brookes S, Martin N, Rapisarda V, Peters G, Gil J. CBX7 and miR-9 are part of an autoregulatory loop controlling p16(INK) (4a). Aging Cell. 2015;14:1113\u201321.","journal-title":"Aging Cell"},{"key":"7306_CR31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/tox.22988","volume":"35","author":"L Chen","year":"2020","unstructured":"Chen L, Xia JS, Wu JH, Chen YG, Qiu CJ. Resveratrol inhibits oral squamous cell carcinoma cells proliferation while promoting apoptosis through inhibition of CBX7 protein. Environ Toxicol. 2020;35:1234\u201340.","journal-title":"Environ Toxicol"},{"key":"7306_CR32","first-page":"5292","volume":"24","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Liu XL, Huang JH, Yin AJ, Zhang H. MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK\/MAPK signaling pathway and epithelial-to-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2020;24:5292\u2013302.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7306_CR33","first-page":"64","volume":"7","author":"W Wu","year":"2017","unstructured":"Wu W, Zhou X, Yu T, Bao Z, Zhi T, Jiang K, Nie E, Wang Y, Zhang J, You Y. The malignancy of miR-18a in human glioblastoma via directly targeting CBX7. Am J Cancer Res. 2017;7:64\u201376.","journal-title":"Am J Cancer Res"},{"key":"7306_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nm0417-526c","volume":"23","author":"F Braso-Maristany","year":"2017","unstructured":"Braso-Maristany F, Filosto S, Catchpole S, Marlow R, Quist J, Francesch-Domenech E, Plumb DA, Zakka L, Gazinska P, Liccardi G, et al. Erratum: PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer. Nat Med. 2017;23:526.","journal-title":"Nat Med"},{"key":"7306_CR35","unstructured":"Li Z, Wang H, Wang G, Zhang A, Wang C, Mo L, Jia Z, Tong X. Expression and prognostic value of PIM-1 kinase in gliomas. Histol Histopathol. 2024;18845."},{"key":"7306_CR36","doi-asserted-by":"publisher","first-page":"106565","DOI":"10.1016\/j.leukres.2021.106565","volume":"106","author":"L Wu","year":"2021","unstructured":"Wu L, Xia L, Chen X, Ruan M, Li L, Xia R. Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p\/PIM1 axis. Leuk Res. 2021;106:106565.","journal-title":"Leuk Res"},{"key":"7306_CR37","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/leu.2016.379","volume":"31","author":"JR Nair","year":"2017","unstructured":"Nair JR, Caserta J, Belko K, Howell T, Fetterly G, Baldino C, Lee KP. Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma. Leukemia. 2017;31:1715\u201326.","journal-title":"Leukemia"},{"key":"7306_CR38","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/acel.12249","volume":"13","author":"B Jin","year":"2014","unstructured":"Jin B, Wang Y, Wu CL, Liu KY, Chen H, Mao ZB. PIM-1 modulates cellular senescence and links IL-6 signaling to heterochromatin formation. Aging Cell. 2014;13:879\u201389.","journal-title":"Aging Cell"},{"key":"7306_CR39","doi-asserted-by":"publisher","first-page":"L685","DOI":"10.1152\/ajplung.00023.2022","volume":"323","author":"AY Gao","year":"2022","unstructured":"Gao AY, Diaz Espinosa AM, Giani F, Pham TX, Carver CM, Aravamudhan A, Bartman CM, Ligresti G, Caporarello N, Schafer MJ, Haak AJ. Pim-1 kinase is a positive feedback regulator of the senescent lung fibroblast inflammatory secretome. Am J Physiol Lung Cell Mol Physiol. 2022;323:L685\u201397.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7306_CR40","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1158\/1541-7786.MCR-10-0174","volume":"8","author":"M Zemskova","year":"2010","unstructured":"Zemskova M, Lilly MB, Lin YW, Song JH. Kraft AS: p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase. Mol Cancer Res. 2010;8:1126\u201341.","journal-title":"Mol Cancer Res"},{"key":"7306_CR41","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1038\/onc.2017.96","volume":"36","author":"J Yang","year":"2017","unstructured":"Yang J, Liu K, Yang J, Jin B, Chen H, Zhan X, Li Z, Wang L, Shen X, Li M, et al. PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311. Oncogene. 2017;36:4828\u201342.","journal-title":"Oncogene"},{"key":"7306_CR42","doi-asserted-by":"publisher","first-page":"d369","DOI":"10.2741\/999","volume":"8","author":"M Torres","year":"2003","unstructured":"Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front Biosci. 2003;8:d369\u2013391.","journal-title":"Front Biosci"},{"key":"7306_CR43","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1101\/gad.12.19.3008","volume":"12","author":"AW Lin","year":"1998","unstructured":"Lin AW, Barradas M, Stone JC, van Aelst L, Serrano M, Lowe SW. Premature senescence involving p53 and p16 is activated in response to constitutive MEK\/MAPK mitogenic signaling. Genes Dev. 1998;12:3008\u201319.","journal-title":"Genes Dev"},{"key":"7306_CR44","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1101\/gad.203984.112","volume":"27","author":"X Deschenes-Simard","year":"2013","unstructured":"Deschenes-Simard X, Gaumont-Leclerc MF, Bourdeau V, Lessard F, Moiseeva O, Forest V, Igelmann S, Mallette FA, Saba-El-Leil MK, Meloche S, et al. Tumor suppressor activity of the ERK\/MAPK pathway by promoting selective protein degradation. Genes Dev. 2013;27:900\u201315.","journal-title":"Genes Dev"},{"key":"7306_CR45","doi-asserted-by":"crossref","unstructured":"Kuk MU, Kim D, Lee YH, Yoon JH, Park JH, Lee YJ, So BH, Kim M, Kwon HW, Byun Y, Park JT. Synergistic ROS Reduct Through The Co-Inhib Of BRAF And p38 MAPK Ameliorates Senescence. Antioxid (basel). 2024;13.","DOI":"10.3390\/antiox13121465"},{"key":"7306_CR46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41419-021-03819-0","volume":"12","author":"Z Huang","year":"2021","unstructured":"Huang Z, Yan Y, Zhu Z, Liu J, He X, Dalangood S, Li M, Tan M, Cai J, Tang P, et al. CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10-ERK signaling. Cell Death Dis. 2021;12:537.","journal-title":"Cell Death Dis"},{"key":"7306_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7150\/jca.15838","volume":"8","author":"L Mologni","year":"2017","unstructured":"Mologni L, Magistroni V, Casuscelli F, Montemartini M, Gambacorti-Passerini C. The novel PIM1 inhibitor NMS-P645 reverses PIM1-dependent effects on TMPRSS2\/ERG positive prostate cancer cells and shows Anti-proliferative activity in combination with PI3K inhibition. J Cancer. 2017;8:140\u201345.","journal-title":"J Cancer"},{"key":"7306_CR48","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.110.963314","volume":"123","author":"R Paulin","year":"2011","unstructured":"Paulin R, Courboulin A, Meloche J, Mainguy V, Dumas de la Roque E, Saksouk N, Cote J, Provencher S, Sussman MA, Bonnet S. Signal transducers and activators of transcription-3\/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation. 2011;123:1205\u201315.","journal-title":"Circulation"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07306-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07306-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07306-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T19:04:50Z","timestamp":1763406290000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-07306-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7306"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07306-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Anhui Medical University, and informed consent was obtained from the patients. Animal experiments were approved by the Experimental Animal Center Committee of the Hefei Comprehensive National Science Center Institute of Health and Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"1292"}}